The purpose of this grant program is to promote research aimed at finding a specific
treatment for fragile X syndrome. FRAXA's goal is to bring practical
treatment into current medical practice as quickly as possible; therefore,
preference will be given to research projects that have a clear practical
application and the results of which will be shared with other qualified
researchers in a timely fashion.
FRAXA is particularly interested in preclinical studies of potential pharmaceutical and
genetic treatments and studies aimed at understanding the function of the FMR1 gene.
more
Fellowships of up to $40,000 per year will be offered to support postdoctoral
fellows who want to pursue research in fragile X (salary plus fringe benefits
and/or travel to meetings).
FRAXA also invites investigator-initiated research applications for innovative
pilot studies aimed at developing and characterizing new therapeutic approaches
for the treatment and ultimate cure of fragile X syndrome. There is no funding
limit to this category of grant; typical funding levels are $30K - 60K.
Applications are accepted on February 1st each year. more
